XML 42 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans $ 27.6 $ 27.1 $ 58.1 $ 59.5
Stock-based compensation expense related to stock options, SAR and ESPP grants $ 11.1 $ 13.0 $ 22.1 $ 26.2
Performance Units and Performance Stock Disclosures [Abstract]        
Common Shares Available for Grant 20,900,000   20,900,000  
Unrecognized compensation expense $ 75.6   $ 75.6  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 3 months 18 days  
Stock Options and SARs [Member]        
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 26.64 $ 21.04
Expected Volatility (in hundredths)     30.46% 35.90%
Risk-Free Interest Rate (in hundredths)     1.39% 0.93%
Dividend Yield (in hundredths)     0.68% 0.91%
Expected Life (in years)     5 years 3 months 18 days 5 years 3 months 18 days
Stock Options and SARs Rollforward [Abstract]        
Outstanding at January 1 (in shares)     9,850,000 10,744,000
Granted (in shares)     16,000 11,000
Exercised (1) (in shares) [1]     (783,000) (790,000)
Forfeited (in shares)     (189,000) (150,000)
Outstanding at June 30 (2) (in shares) [2] 8,894,000 9,815,000 8,894,000 9,815,000
Stock Options and SARs Vested or Expected to Vest (in shares) [3] 8,594,000 9,490,000 8,594,000 9,490,000
Stock Options and SARs Exercisable at June 30 (in shares) [4] 4,973,000 5,638,000 4,973,000 5,638,000
Intrinsic Value of Stock Options/SARs Exercised     $ 33.5 $ 26.8
Intrinsic Value of Stock Options/SARs Outstanding $ 147.8 $ 173.1 $ 147.8 $ 173.1
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding     3 years 7 months 6 days 3 years 7 months 6 days
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest 145.7 170.3 $ 145.7 $ 170.3
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years)al Term     3 years 6 months 3 years 7 months 6 days
Aggregate Intrinsic Value for Exercisable Units $ 120.9 $ 137.7 $ 120.9 $ 137.7
Weighted average remaining contractual life for exercisable options/SARs (in years)     2 years 2 months 12 days 2 years 4 months 24 days
Weighted Average Grant Price Stock Option and SARs [Rollforward]        
Outstanding at January 1 (price per share)     $ 75.53 $ 67.98
Granted (price per share)     96.41 71.51
Exercised (1) (price per share) [1]     57.05 44.31
Forfeited (price per share)     89.40 85.91
Outstanding at June 30 (2) (price per share) [2] $ 76.90 $ 69.61 76.90 69.61
Vested or Expected to Vest (3) (price per share) [3] 76.53 69.24 76.53 69.24
Exercisable at June 30 (4) (price per share) [4] $ 68.43 $ 61.50 68.43 61.50
ESPP [Member]        
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 24.28 $ 17.56
Expected Volatility (in hundredths)     30.33% 36.79%
Risk-Free Interest Rate (in hundredths)     0.65% 0.49%
Dividend Yield (in hundredths)     0.69% 0.82%
Expected Life (in years)     6 months 6 months
Restricted Stock And Restricted Stock Units [Member]        
Restricted Stock/Restricted Stock Units [Roll Forward]        
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost $ 15.6 $ 13.7 $ 34.2 $ 32.4
Outstanding at January 1 (in shares)     3,962,000 4,908,000
Granted (in shares)     437,000 306,000
Released (1) (in shares) [5]     (407,000) (798,000)
Forfeited (in shares)     (143,000) (203,000)
Outstanding at June 30 (2) (in shares) [6] 3,849,000 4,213,000 3,849,000 4,213,000
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward]        
Outstanding at January 1 (price per share)     $ 79.63 $ 70.35
Granted (price per share)     98.97 75.56
Released (1) (price per share) [5]     63.20 61.36
Forfeited (price per share)     83.92 76.97
Outstanding at June 30 (2) (price per share) [6] $ 83.40 $ 72.11 $ 83.40 $ 72.11
Performance Units and Performance Stock Disclosures [Abstract]        
Intrinsic value released during the year     $ 40.4 $ 60.8
Aggregate intrinsic value of stock and units outstanding $ 348.4 $ 351.5 348.4 351.5
Unrecognized compensation expense 151.1   $ 151.1  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 6 months  
Performance Units and Performance Stock [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans $ 0.9 0.4 $ 1.8 0.9
Restricted Stock/Restricted Stock Units [Roll Forward]        
Outstanding at January 1 (in shares)     545,290  
Granted (in shares)     118,834  
Released (1) (in shares)     (89,224)  
Outstanding at June 30 (2) (in shares) 574,900   574,900  
Performance Units and Performance Stock Disclosures [Abstract]        
Performance Period for Performance Units and Shares     3 years  
Minimum Performance Units and Stock Allowed to be Outstanding     299,540  
Minimum Performance Multiple at the Completion of the Performance Period     0.00%  
Maximum Performance Multiple at the Completion of the Performance Period     200.00%  
Maximum Vest Period from the Date of Grant     5 years  
Maximum Performance Units and Stock Allowed to be Outstanding     850,260  
Intrinsic value released during the year     $ 9.0  
Aggregate intrinsic value of stock and units outstanding $ 52.0   52.0  
Unrecognized compensation expense 8.6   $ 8.6  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 6 months  
Lease And Well [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans 9.6 8.9 $ 20.5 19.3
Gathering And Processing Costs [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans 0.2 0.3 0.4 0.6
Exploration Costs [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans 5.3 5.0 11.5 11.5
General And Administrative [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans $ 12.5 $ 12.9 $ 25.7 $ 28.1
[1] The total intrinsic value of stock options/SARs exercised for the six months ended June 30, 2017 and 2016 was $33.5 million and $26.8 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs.
[2] The total intrinsic value of stock options/SARs outstanding at June 30, 2017 and 2016 was $147.8 million and $173.1 million, respectively. At June 30, 2017 and 2016, the weighted average remaining contractual life was 3.6 years and 3.6 years, respectively.
[3] The total intrinsic value of stock options/SARs vested or expected to vest at June 30, 2017 and 2016 was $145.7 million and $170.3 million, respectively. At June 30, 2017 and 2016, the weighted average remaining contractual life was 3.5 years and 3.6 years, respectively.
[4] The total intrinsic value of stock options/SARs exercisable at June 30, 2017 and 2016 was $120.9 million and $137.7 million, respectively. At June 30, 2017 and 2016, the weighted average remaining contractual life was 2.2 years and 2.4 years, respectively.
[5] The total intrinsic value of restricted stock and restricted stock units released for the six months ended June 30, 2017 and 2016 was $40.4 million and $60.8 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
[6] The total intrinsic value of restricted stock and restricted stock units outstanding at June 30, 2017 and 2016 was $348.4 million and $351.5 million, respectively.